Proteins involved in the PI3K/AKT pathway as well as mitochondrial regulator proteins (widely studied in aging-associated diseases such as Parkinson’s disease and Alzheimer’s disease) were evaluated after BMI1 silencing to further elucidate the mechanism by which BMI1 acts in mitochondrial function. This evidence concerns the gene AKT1 and early-onset autosomal dominant Alzheimer disease.